Kingsview Wealth Management LLC Grows Holdings in Colgate-Palmolive (NYSE:CL)

Kingsview Wealth Management LLC lifted its position in shares of Colgate-Palmolive (NYSE:CL) by 133.9% during the 4th quarter, HoldingsChannel reports. The fund owned 36,120 shares of the company’s stock after purchasing an additional 20,676 shares during the period. Kingsview Wealth Management LLC’s holdings in Colgate-Palmolive were worth $3,284,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of CL. Apollon Wealth Management LLC grew its stake in Colgate-Palmolive by 12.2% in the 4th quarter. Apollon Wealth Management LLC now owns 25,317 shares of the company’s stock valued at $2,302,000 after acquiring an additional 2,746 shares during the period. Vest Financial LLC lifted its holdings in Colgate-Palmolive by 13.9% during the fourth quarter. Vest Financial LLC now owns 575,181 shares of the company’s stock valued at $52,290,000 after purchasing an additional 69,982 shares in the last quarter. Conning Inc. grew its position in shares of Colgate-Palmolive by 13.1% in the fourth quarter. Conning Inc. now owns 391,017 shares of the company’s stock valued at $35,547,000 after purchasing an additional 45,281 shares during the period. Platform Technology Partners increased its stake in shares of Colgate-Palmolive by 2.8% during the fourth quarter. Platform Technology Partners now owns 15,851 shares of the company’s stock worth $1,441,000 after purchasing an additional 432 shares in the last quarter. Finally, Slocum Gordon & Co LLP raised its position in shares of Colgate-Palmolive by 486.5% during the 4th quarter. Slocum Gordon & Co LLP now owns 23,026 shares of the company’s stock worth $2,093,000 after purchasing an additional 19,100 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of CL opened at $86.81 on Monday. The company has a market capitalization of $70.93 billion, a price-to-earnings ratio of 24.66, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The stock has a 50 day moving average price of $90.36 and a 200 day moving average price of $96.77.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business posted $0.87 EPS. Research analysts predict that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Wall Street Analysts Forecast Growth

CL has been the subject of several research reports. Stifel Nicolaus cut their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.